Brexucabtagene autoleucel

Generic name: Brexucabtagene Autoleucel
Brand names: Tecartus
Dosage form: intravenous suspension (-)
Drug class: Miscellaneous antineoplastics

Usage of Brexucabtagene autoleucel

Brexucabtagene autoleucel is an immunotherapy medicine used to treat mantle cell lymphoma in adults. brexucabtagene autoleucel is given after other treatments did not work or have stopped working.

Brexucabtagene autoleucel is made using white blood cells removed from blood that is drawn from your body through a vein.

Brexucabtagene autoleucel may also be used for purposes not listed in this medication guide.

Brexucabtagene autoleucel side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

A common but serious side effect of this medicine is called cytokine release syndrome (CRS). Tell your caregivers right away if you have signs of this condition: fever, chills, dizziness, confusion, vomiting, diarrhea, fast heartbeats, trouble breathing, or feeling very weak or tired. Your caregivers will have medication available to quickly treat CRS if it occurs.

Brexucabtagene autoleucel may cause serious side effects. Call your doctor at once if you have:

severe drowsiness;

trouble speaking or writing;

trouble with daily activities;

a seizure;

severe ongoing nausea, vomiting, or diarrhea;

low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath;

kidney problems--little or no urination, swelling in your feet or ankles, feeling tired or short of breath; or

fluid build-up in or around the lungs--pain when you breathe, feeling short of breath while lying down, wheezing, gasping for breath, cough with foamy mucus, cold and clammy skin, anxiety, rapid heartbeats.

You may need to be treated in a hospital if you have certain side effects.

Common side effects of brexucabtagene autoleucel may include:

slurred speech;

fever, chills, cough, or other signs of infection;

feeling tired or light-headed;

fast or irregular heartbeats;

tremor, problems with speech or muscle movement;

headache, muscle or joint pain;

nausea, loss of appetite;

diarrhea, constipation;

swelling, kidney problems;

rash; or

sleep problems (insomnia).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Brexucabtagene autoleucel

You should not be treated with this medicine while you have an active infection (such as fever, chills, flu-like symptoms).

Tell your doctor if you have ever had:

an active or chronic infection;

a stroke;

a seizure;

memory problems;

breathing problems;

hepatitis B or C;

HIV;

heart problems;

liver disease;

kidney disease; or

if you have received a vaccine within the past 6 weeks.

Using brexucabtagene autoleucel may increase your risk of developing other cancers, such as leukemia. Ask your doctor about this risk.

You may need to have a negative pregnancy test before starting this treatment.

Tell your doctor if you are pregnant. Brexucabtagene autoleucel may harm an unborn baby. Use effective birth control to prevent pregnancy. Talk with your doctor if you plan to become pregnant after you are treated with this medicine.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

Relate drugs

How to use Brexucabtagene autoleucel

Usual Adult Dose for Lymphoma:

PRETREATMENT: Administer a lymphodepleting chemotherapy regimen of cyclophosphamide 500 mg/m2 IV and fludarabine 30 mg/m2 IV on each of the fifth, fourth, and third days before infusing this drug. Each single infusion bag contains a suspension of chimeric antigen receptor (CAR)-positive T cells in approximately 68 mL; the dose is 2 x 10(6) CAR-positive viable T cells/kg, with a maximum of 2 x 10(8) CAR-positive viable T cellsComments:-Premedicate with acetaminophen and diphenhydramine or another H1-antihistamine approximately 30 to 60 minutes prior to infusing this drug.-Avoid prophylactic use of systemic corticosteroids as it may interfere with the activity of this drug.Use: For the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL)

Warnings

A common but serious side effect of brexucabtagene autoleucel is called cytokine release syndrome, which causes fever, chills, trouble breathing, vomiting, and other symptoms. Your caregivers will have medication available to quickly treat this condition if it occurs.

What other drugs will affect Brexucabtagene autoleucel

Other drugs may affect brexucabtagene autoleucel, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.